🇺🇸 FDA
Patent

US 7301004

Process for preparing glycopeptide phosphonate derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 7301004 (Process for preparing glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P31/04